We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The UK’s Medicines and healthcare Regulatory Agency (MHRA) is focused on building diagnostic capability for COVID-19 infections and is ramping up testing facilities across the UK via partnerships with universities, research institutes, diagnostics manufacturers and companies like Amazon and Boots.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor